Follow us
Nigeria Health Watch
Follow us:
Subscribe to our Newsletter
breadcrumb banner

Lassa Fever

Search

Categories

Recent Posts

Post Image

As Efforts Intensify to Contain Bundibugyo Ebola, Women Remain Most Vulnerable to Its Economic Impact

Jul 06, 2026
Post Image

An Epidemic of Parastatals in Nigeria’s Health Sector

Jul 04, 2026
Post Image

From Innovation to Integration: What It Will Take to Make Every Pregnancy Safer in Nigeria

Jul 03, 2026
Post Image

Community Feedback Prompts PHC Upgrade in Gauraka, Niger State

Jul 03, 2026
Post Image

Why Zambia is Rethinking Tuberculosis Testing, and Why Validation Must Come First

Jul 02, 2026
Blog Image 2 Oct

Largest-ever Lassa fever study launches in-depth look at disease symptom

By Nigeria Health Watch | October 2, 2024

Scientists in Nigeria are expanding their research into the deadly Lassa fever with the launch of a pioneering study designed to get a better idea of the variation in disease symptoms and how these compare to malaria and other worrisome infections found in the region.  The new research, led by the Nigeria Centre for Disease […]

Read More
Blog Image 13 Sep

Ten Years After Ebola: Learnings for Lassa Fever, “Lassa-X” and Pandemic Preparedness

By Nigeria Health Watch | September 13, 2024

Oluomachukwu Omeje (Lead Writer) In global health, past epidemics are important learning experiences that shape our responses to future health emergencies. The 2014 Ebola epidemic in West Africa serves as a stark reminder of the vulnerabilities and strengths of public health systems. As the world continues to face emerging and re-emerging infectious diseases, the lessons […]

Read More
Blog Image 4 Apr

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

By Nigeria Health Watch | April 4, 2024

The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate Key takeaways • Participants in Nigeria have been vaccinated with a Lassa fever vaccine candidate in the first Phase 2 clinical trial of any Lassa vaccine.• Lassa fever is a deadly hemorrhagic fever common to West Africa. […]

Read More
Blog Image 21 Nov

Are we there yet? Leveraging the Private Sector for Lassa Vaccine R&D

By Nigeria Health Watch | November 21, 2023

The search for an effective vaccine against Lassa fever has gained momentum in recent years. Currently, early supportive care and the anti-viral drug Ribavirin are the primary methods of patient treatment. Lassa fever has long been a public health concern in Nigeria and parts of West Africa, since the disease was first identified in 1969. […]

Read More
Blog Image 13 Jul

CEPI: Accelerating Lassa Fever Vaccine Development in Nigeria

By Nigeria Health Watch | July 13, 2023

The law of inertia, referred to as Newton’s first law of motion, states that “an object will remain at rest or in uniform motion in a straight line unless compelled to change its state by the action of an external force”. This is similar to the Coalition for Epidemic Preparedness Innovation’s (CEPI) mission to accelerate […]

Read More